Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA pins protein vaccination

被引:281
作者
Letvin, NL
Montefiori, DC
Yasutomi, Y
Perry, HC
Davies, ME
Lekutis, C
Alroy, M
Freed, DC
Lord, CI
Handt, LK
Liu, MA
Shiver, JW
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[2] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,BOSTON,MA 02215
[3] MERCK RES LABS,DEPT VIRUS & CELL BIOL,W POINT,PA 19486
关键词
CTL; virus neutralization; vaccine; SHIV; T lymphocyte;
D O I
10.1073/pnas.94.17.9378
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It is generally thought that an effective vaccine to prevent HIV-1 infection should elicit both strong neutralizing antibody and cytotoxic T lymphocyte responses, We recently demonstrated that potent, boostable, long-lived HIV-1 envelope (Env)-specific cytotoxic T lymphocyte responses can be elicited in rhesus monkeys using plasmid-encoded HIV-1 env DNA as the immunogen, In the present study, we show that the addition of HIV-I Env protein to this regimen as a boosting immunogen generates a high titer neutralizing antibody response in this nonhuman primate species, Moreover, we demonstrate in a pilot study that immunization with HIV-1 env DNA (multiple doses) followed by a final immunization with HIV-1 env DNA plus HIV-1 Env protein (env gene from HXBc2 clone of HIV IIIB; Env protein from parental HIV IIIB) completely protects monkeys from infection after i.v. challenge with a chimeric virus expressing HIV-1 env (HXBc2) on a simian immunodeficiency virus(mac) backbone (SHIV-HXBc2). The potent immunity and protection seen in these pilot experiments suggest that a DNA prime/DNA plus protein boost regimen warrants active investigation as a vaccine strategy to prevent HIV-1 infection.
引用
收藏
页码:9378 / 9383
页数:6
相关论文
共 25 条
  • [1] Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1
    Berman, PW
    Murthy, KK
    Wrin, T
    Vennari, JC
    Cobb, EK
    Eastman, DJ
    Champe, M
    Nakamura, GR
    Davison, D
    Powell, MF
    Bussiere, J
    Francis, DP
    Matthews, T
    Gregory, TJ
    Obijeski, JF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) : 52 - 59
  • [2] BORROW P, 1994, J VIROL, V68, P5103
  • [3] PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE
    DANIEL, MD
    KIRCHHOFF, F
    CZAJAK, SC
    SEHGAL, PK
    DESROSIERS, RC
    [J]. SCIENCE, 1992, 258 (5090) : 1938 - 1941
  • [4] PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS
    DONNELLY, JJ
    FRIEDMAN, A
    MARTINEZ, D
    MONTGOMERY, DL
    SHIVER, JW
    MOTZEL, SL
    ULMER, JB
    LIU, MA
    [J]. NATURE MEDICINE, 1995, 1 (06) : 583 - 587
  • [5] RESISTANCE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT GP120(SF2) TO CHALLENGE BY HIV-1(SF2)
    ELAMAD, Z
    MURTHY, KK
    HIGGINS, K
    COBB, EK
    HAIGWOOD, NL
    LEVY, JA
    STEIMER, KS
    [J]. AIDS, 1995, 9 (12) : 1313 - 1322
  • [6] DNA VACCINES - PROTECTIVE IMMUNIZATIONS BY PARENTERAL, MUCOSAL, AND GENE-GUN INOCULATIONS
    FYNAN, EF
    WEBSTER, RG
    FULLER, DH
    HAYNES, JR
    SANTORO, JC
    ROBINSON, HL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11478 - 11482
  • [7] PROGRESS IN AIDS VACCINE DEVELOPMENT
    JOHNSTON, MI
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 108 (04) : 313 - 317
  • [8] KINETICS OF GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES DURING THE CLINICAL COURSE OF HIV-1 INFECTION - A LONGITUDINAL ANALYSIS OF RAPID PROGRESSORS AND LONG-TERM ASYMPTOMATICS
    KLEIN, MR
    VANBAALEN, CA
    HOLWERDA, AM
    KERKHOFGARDE, SR
    BENDE, RJ
    KEET, IPM
    EEFTINCKSCHATTENKERK, JKM
    OSTERHAUS, ADME
    SCHUITEMAKER, H
    MIEDEMA, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) : 1365 - 1372
  • [9] TEMPORAL ASSOCIATION OF CELLULAR IMMUNE-RESPONSES WITH THE INITIAL CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNDROME
    KOUP, RA
    SAFRIT, JT
    CAO, YZ
    ANDREWS, CA
    MCLEOD, G
    BORKOWSKY, W
    FARTHING, C
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4650 - 4655
  • [10] Lekutis C, 1997, J IMMUNOL, V158, P4471